Notices. Notice
177 words·~1 min read·
/register/2000/08/24/00-21657·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 5001-05-U DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Deglycosylated Ricin Toxin A-Chain Vaccine AGENCY: U.S. Army Medical Research and Materiel Command, DoD. ACTION: Notice. SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application Serial Number 09/523,271 entitled “Deglycosylated Ricin Toxin A-Chain Vaccine”, filed March 10, 2000.
This patent application has been assigned to the United States Government as represented by the Secretary of the Army. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney,
(301)619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment,
(301)619-6664. Both at telefax
(301)619-5034. SUPPLEMENTARY INFORMATION: A vaccine comprising deglycosylated ricin toxin A-chain and method for making and using the composition. Gregory D. Showalter, Army Federal Register Liaison Officer. [FR Doc. 00-21657 Filed 8-23-00; 8:45 am]
Connectionstraces to 1
Traces to 1 document